Format

Send to

Choose Destination
Leukemia. 2018 Apr;32(4):1044-1048. doi: 10.1038/leu.2017.345. Epub 2017 Dec 6.

Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines.

Author information

1
Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
2
Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK.
3
Hematology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
4
Institute for Biomedical Technologies, National Research Council, Milan, Italy.
5
Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
6
Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA.
7
Department of Bioengineering, University of California, San Diego, La Jolla, CA, USA.
8
Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.
9
Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
10
Department of Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
11
CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France and CHU de Nantes, Nantes, France.
12
Genomics of Myeloma Laboratory, L'Institut Universitaire du Cancer Oncopole, Toulouse, France.
13
Boston Veterans Administration Healthcare System, West Roxbury, MA, USA.
PMID:
29209044
PMCID:
PMC5886048
DOI:
10.1038/leu.2017.345
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center